Fact CheckerSign in

NCT05793125Completed

Pulmonary Artery Doppler And Neonatal Outcome In Hypertensive Disorders Of Pregnancy

Correlation Between Pulmonary Artery Doppler And Neonatal Outcome In Hypertensive Disorders Of Pregnancy

Source: ClinicalTrials.gov · Last updated 15 Nov 2024

Brief summary (registry, in English)

To correlate fetal Pulmonary artery Doppler parameters with neonatal outcome in patients diagnosed with hypertensive disorders of pregnancy.

Status (registry)
Completed
Study type
Observational
Enrollment
72 (actual)
First submitted
19 Mar 2023
Start date
3 Apr 2023
Primary completion date
4 Apr 2024
Lead sponsor
Cairo University
NCT number
NCT05793125

What you commit to

  • Study type: Observational
  • Participants enrolled: 72
  • From 3 Apr 2023 to the primary completion date, 4 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient receiving general anesthesia if termination was by cesarean delivery
  • Patients receiving narcotics 4 hours before delivery

Other illness

  • Emergent cases presenting with fetal distress (bradycardia will be defined as fetal heart rate \< 110 beat per minute)

Lab values

  • Diabetes with pregnancy either gestational or overt which is defined as any degree of glucose intolerance with an onset or first recognition during pregnancy

Other

  • Multifetal pregnancy
  • Intrauterine fetal death
  • Intrauterine growth restriction (IUGR) which is defined as a rate of fetal growth that is less than normal for the growth potential of that specific infant
  • Placental abruption whether diagnosed before or during delivery.
  • Absent or reversed umbilical artery end diastolic flow.
  • Premature or prelabor rupture of membranes
  • BMI above 40 due to technical difficulties to obtain accurate measures
  • Major congenital fetal anomalies whether diagnosed before or after delivery
  • Maternal fever more than 37.4 degree
  • Patients with unreliable dates or no crown rump length at first trimester.

Who the study is looking for

  • Age: 18-42 years old
  • Patients who will be diagnosed with hypertensive disorders of pregnancy preoperatively according to (ACOG 2020)
  • Those who will undergo elective or emergency termination of pregnancy whether by vaginal or cesarean delivery .
  • Primi or multigravida
  • With gestational age: 28 0/7 - 37 6/7 weeks

Age in the registry: 18 years to 42 years · Sex: Female

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kasralainy Cairo University
Coordinator of this site? Confirm its status
GizaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.